Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.

Li, Ying-Xue; Ding, Shan-Shan; Wen, Wen-Juan; Han, Lin; Wang, Hong-Qun; Shi, Huai-Yin

Li, Ying-Xue; Ding, Shan-Shan; Wen, Wen-Juan; Han, Lin; Wang, Hong-Qun; Shi, Huai-Yin.

Afiliación

Li YX; Department of Pathology, Medical School of Chinese People's Liberation Army, Beijing 100853, People's Republic of China.
Ding SS; Department of Pathology, Liaocheng People's Hospital, Liaocheng 252000, Shandong, People's Republic of China.
Wen WJ; Department of Pathology, PLA Rocket Force Characteristic Medical Center, Beijing 100032, People's Republic of China.
Han L; Department of Pathology, Liaocheng People's Hospital, Liaocheng 252000, Shandong, People's Republic of China.
Wang HQ; Department of Pathology, Liaocheng People's Hospital, Liaocheng 252000, Shandong, People's Republic of China.
Shi HY; Department of Pathology, Medical School of Chinese People's Liberation Army, Beijing 100853, People's Republic of China.

Cancer Manag Res ; 12: 1759-1769, 2020.

Article en En | MEDLINE | ID: mdl-32210617

Palabras clave

clinicopathologic features; p4E-BP1; pAkt; pmTOR; prognosis; synovial sarcoma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Manag Res Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google